cysteine and Scleroderma, Systemic

cysteine has been researched along with Scleroderma, Systemic in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's2 (25.00)18.2507
2000's3 (37.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bjermer, L; Bozovic, G; Hesselstrand, R; Scheja, A; Tufvesson, E; Wuttge, DM1
del Rosso, A; Distler, JH; Distler, O; Gay, RE; Gay, S; Hagen, C; Hirth, A; Kalden, JR; Lorenz, HM; Matucci-Cerinic, M; Michel, BA; Müller-Ladner, U; Nanagara, R; Nishioka, K1
Berezné, A; Guillevin, L; Mouthon, L; Poiraudeau, S1
Sule, SD; Wigley, FM1
Hara, M; Harigai, M; Hidaka, T; Ishizuka, T; Kawagoe, M; Kawaguchi, Y; Kawakami, M; Kitani, A; Nakamura, H; Suzuki, K1
Endo, S; Furuya, R; Hishida, A; Itoh, M; Ogawa, N; Ohashi, H; Okugawa, T; Sudo, Y1
Emerit, I; Housset, E; Levy, A1
Henkin, RI1

Reviews

3 review(s) available for cysteine and Scleroderma, Systemic

ArticleYear
[Therapeutic management of systemic sclerosis].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:12 Pt 2

    Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cyclophosphamide; Cysteine; Epoprostenol; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Interferons; Lung Diseases, Interstitial; Orthotic Devices; Penicillamine; Peripheral Blood Stem Cell Transplantation; Physical Therapy Modalities; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Scleroderma, Systemic; Vasodilator Agents

2006
Novel therapy in the treatment of scleroderma.
    Expert opinion on investigational drugs, 2001, Volume: 10, Issue:1

    Topics: Autoimmune Diseases; Bone Marrow Transplantation; Cysteine; Humans; Interferon-gamma; Nitric Oxide; Piperidines; Prostaglandins; Quinazolines; Quinazolinones; Relaxin; Scleroderma, Systemic; Tetracycline; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha

2001
Metal-albumin-amino acid interactions: chemical and physiological interrelationships.
    Advances in experimental medicine and biology, 1974, Volume: 48, Issue:0

    Topics: Albumins; Amino Acids; Animals; Cadmium; Chromatography, Gel; Copper; Cysteine; Dose-Response Relationship, Drug; Histidine; Humans; In Vitro Techniques; Kinetics; Male; Protein Binding; Radioisotopes; Rats; Scleroderma, Systemic; Zinc; Zinc Isotopes

1974

Trials

1 trial(s) available for cysteine and Scleroderma, Systemic

ArticleYear
Effect of prolyl 4-hydroxylase inhibitor on fibroblast collagen production in vitro: an approach to the treatment of systemic sclerosis.
    The Journal of rheumatology, 1992, Volume: 19, Issue:11

    Topics: Blotting, Northern; Collagen; Cysteine; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Fibronectins; Humans; Hydroxyproline; Naphthoquinones; Procollagen; Procollagen-Proline Dioxygenase; RNA, Messenger; Scleroderma, Systemic

1992

Other Studies

4 other study(ies) available for cysteine and Scleroderma, Systemic

ArticleYear
Increased cysteinyl-leukotrienes and 8-isoprostane in exhaled breath condensate from systemic sclerosis patients.
    Rheumatology (Oxford, England), 2010, Volume: 49, Issue:12

    Topics: Adult; Aged; Biomarkers; Breath Tests; Case-Control Studies; Cysteine; Exhalation; Female; Forced Expiratory Volume; Humans; Immunologic Factors; Isoprostanes; Leukotrienes; Male; Middle Aged; Oxidative Stress; Scleroderma, Systemic

2010
Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-kappaB and simian virus 40 promoter factor 1 pathways.
    Molecular pharmacology, 2004, Volume: 65, Issue:2

    Topics: Cells, Cultured; Cysteine; Dose-Response Relationship, Drug; Fibroblasts; Humans; NF-kappa B; Plicamycin; RNA, Messenger; Scleroderma, Systemic; Simian virus 40; Sp1 Transcription Factor; Vascular Endothelial Growth Factor A

2004
[A case of progressive systemic sclerosis with Sjögren's syndrome complicated by nephrotic syndrome caused by bucillamine].
    Ryumachi. [Rheumatism], 1990, Volume: 30, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cysteine; Female; Humans; Middle Aged; Nephrotic Syndrome; Scleroderma, Systemic; Sjogren's Syndrome

1990
Breakage factor in systemic sclerosis and protector effect of L-cysteine.
    Humangenetik, 1974, Volume: 25, Issue:3

    Topics: Cells, Cultured; Chromatids; Chromosome Aberrations; Chromosomes; Culture Media; Cysteine; Humans; Lymphocytes; Mitosis; Scleroderma, Systemic

1974